Retinal Implants Market Research Report – Forecast to 2027

Global Retinal Implants Market Research Report: By Type (Argus II, Implantable Miniature Telescope, Retina Implant Alpha AMS) and By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA), Latin America) – Forecast to 2027

ID: MRFR/MED/5118-HCR | February, 2021 | Region : Global

Market Forecast


Global Retinal Implants Market likely to exhibit a healthy growth over the next couple of years. Retinal implants have emerged as an innovative technology in the field of ophthalmology. They are being used for improving eyesight of people with partial or complete blindness. The technology is still in its nascent stage hence a mixed speculation continues to hover around it. Investment in retinal implants and prostheses R&D has increased in recent years owing to their immense market potential. Several private eyecare companies have entered the frame and are focusing on introducing more effective retinal implants. Majority of retinal implants that are currently available in the market are aimed at partially restoring useful eye vision. Such implants are effective in treating vision loss caused due to age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Visual devices such as bionic eye and visual prosthesis are expected to have bigger impact in years to come, which in turn will pave the way for retinal implant market.


Report Synopsis


This MRFR report offers a thorough analysis of the global retinal implants market. The primary objective of the report is to analyze the current market landscape and its future potential. All the relevant parameters have been considered for market analysis. The report also includes a discussion on the growth opportunities, drivers and restraints. 


Competition Tracking


Philips Healthcare, Retina Implant AG, Second Sight Medical Products, Inc. Bionic Eye Technologies, Inc., Bionic Vision Australia, VisionCare Ophthalmic Technologies, Inc, Abbott Vascular.


The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.


Research Methodology


Market Research Future (MRFR) employs a multi-layered analysis module for presenting accurate industry outlook. The combination of primary and secondary research processes for analysis of governing factors and macro-economic indicators of the market. Detailed surveys and interviews are conducted with key opinion makers across the value chain for collection of primary data. Secondary research processes are leveraged for verification of collected data through valuable inputs from SEC filings, white paper references, paid databases, research publications and other credible sources available in public domain. Additionally, top-down and bottom-up approaches are utilized to extrapolate data, which is then verified using a powerful data triangulation technique. These comprehensive research methods ensure accuracy and objectivity of the market foresight.


For the scope of the research, MRFR’s report offers a comprehensive segmental analysis of the global market for petroleum coke (fuel-grade)


By Type



  • Argus II

  • Implantable Miniature Telescope

  • Retina Implant Alpha AMS


By Region



  • North America

  • Europe

  • Asia Pacific

  • The Middle East & Africa (MEA)

  • Latin America

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Retinal Implants, by Device Type

6.1 Introduction

6.2 Retinal Implants AMS

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Implantable Miniature Telescope (IMT)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Argus II

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Others

Chapter 7. Global Retinal Implants, by End User

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Others

Chapter 8. Global Retinal Implants, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Philips Healthcare

10.1.1 Company Overview

10.1.2 Treatment Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Retina Implant AG

10.2.1 Company Overview

10.2.2 Treatment Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Second Sight Medical Products, Inc.

10.3.1 Company Overview

10.3.2 Treatment Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Bionic Eye Technologies, Inc.

10.4.1 Company Overview

10.4.2 Treatment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 VisionCare Ophthalmic Technologies, Inc.

10.5.1 Company Overview

10.5.2 Treatment Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Abbott Vascular

10.6.1 Company Overview

10.6.2 Treatment Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 IMI INTELLIGENT MEDICAL IMPLANTS AG

10.7.1 Overview

10.7.2 Treatment Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Pixium Vision SA

10.8.1 Overview

10.8.2 Treatment Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Others

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Retinal Implants Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Retinal Implants Synopsis, 2020-2027

Table 2 Global Retinal Implants Estimates and Forecast, 2020-2027

(USD Million)

Table 3 Global Retinal Implants, by Region, 2020-2027 (USD Million)

Table 4 Global Retinal Implants, by Device Type, 2020-2027 (USD Million)

Table 5 Global Retinal Implants, by End User, 2020-2027 (USD Million)

Table 6 North America: Retinal Implants, by Device Type, 2020-2027 (USD

Million)

Table 7 North America: Retinal Implants, by End User, 2020-2027 (USD Million)

Table 8 US: Retinal Implants, by Device Type, 2020-2027 (USD Million)

Table 9 US: Retinal Implants, by End User, 2020-2027 (USD Million)

Table 10 Canada: Retinal Implants, by Device Type, 2020-2027 (USD Million)

Table 11 Canada: Retinal Implants,by End User, 2020-2027 (USD Million)

Table 12 South America: Retinal Implants, by Device Type, 2020-2027 (USD

Million)

Table 13 South America: Retinal Implants, by End User, 2020-2027 (USD

Million)

Table 14 Europe: Retinal Implants, by Device Type, 2020-2027 (USD Million)

Table 15 Europe: Retinal Implants, by End User, 2020-2027 (USD Million)

Table 16 Western Europe: Retinal Implants, by Device Type, 2020-2027 (USD

Million)

Table 17 Western Europe: Retinal Implants, by End User, 2020-2027 (USD

Million)

Table 18 Eastern Europe: Retinal Implants, by Device Type, 2020-2027 (USD

Million)

Table 19 Eastern Europe: Retinal Implants, by End User, 2020-2027 (USD

Million)

Table 20 Asia-Pacific: Retinal Implants, by Device Type, 2020-2027 (USD

Million)

Table 21 Asia-Pacific: Retinal Implants, by End User, 2020-2027 (USD Million)

Table 22 Middle East & Africa: Retinal Implants, by Device Type, 2020-2027

(USD Million)

Table 23 Middle East & Africa: Retinal Implants, by End User, 2020-2027 (USD

Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Retinal Implants

Figure 3 Segmentation Market Dynamics for Global Retinal Implants

Figure 4 Global Retinal Implants Share, by Device Type, 2020

Figure 5 Global Retinal Implants Share, by End User, 2020

Figure 6 Global Retinal Implants Share, by Region, 2020

Figure 7 North America: Retinal Implants Share, by Country, 2020

Figure 8 Europe: Retinal Implants Share, by Country, 2020

Figure 9 Asia-Pacific: Retinal Implants Share, by Country, 2020

Figure 10 Middle East & Africa: Retinal Implants Share, by Country, 201

Figure 11 Global Retinal Implants: Company Share Analysis, 2020 (%)

Figure 12 Philips Healthcare: Key Financials

Figure 13 Philips Healthcare: Segmental Revenue

Figure 14 Philips Healthcare: Geographical Revenue

Figure 15 Retina Implant AG: Key Financials

Figure 16 Retina Implant AG: Segmental Revenue

Figure 17 Retina Implant AG: Geographical Revenue

Figure 18 Second Sight Medical Products, Inc.: Key Financials

Figure 19 Second Sight Medical Products, Inc.: Segmental Revenue

Figure 20 Second Sight Medical Products, Inc.: Geographical Revenue

Figure 21 Bionic Eye Technologies, Inc.: Key Financials

Figure 22 Bionic Eye Technologies, Inc.: Segmental Revenue

Figure 23 Bionic Eye Technologies, Inc.: Geographical Revenue

Figure 24 VisionCare Ophthalmic Technologies, Inc.: Key Financials

Figure 25 VisionCare Ophthalmic Technologies, Inc.: Segmental Revenue

Figure 26 VisionCare Ophthalmic Technologies, Inc.: Geographical Revenue

Figure 27 Abbott Vascular : Key Financials

Figure 28 Abbott Vascular : Segmental Revenue

Figure 29 Abbott Vascular : Geographical Revenue

Figure 30 IMI INTELLIGENT MEDICAL IMPLANTS AG: Key Financials

Figure 31 IMI INTELLIGENT MEDICAL IMPLANTS AG: Segmental Revenue

Figure 32 IMI INTELLIGENT MEDICAL IMPLANTS AG: Geographical Revenue

Figure 33 Pixium Vision SA: Key Financials

Figure 34 Pixium Vision SA: Segmental Revenue

Figure 35 Pixium Vision SA: Geographical Revenue